US Federal House Bill HB379

US Federal 2025-2026 Regular Session

• Introduced: 1/14/25
• Refer: 1/14/25

Caption

Healthcare Freedom and Choice Act

Summary

HB379, titled the "Healthcare Freedom and Choice Act," would nullify a federal rule issued in 2024 by the IRS, the Employee Benefits Security Administration, and the Department of Health and Human Services concerning short-term, limited-duration insurance and independent, noncoordinated excepted benefits coverage. In practical terms, the bill would make that rule have no force or effect, preventing the federal standards in the 2024 regulation from taking effect or remaining operative. The bill is a direct legislative disapproval of a federal health insurance rule rather than a broader rewrite of insurance law. Its purpose is to preserve greater flexibility for short-term health plans and related excepted benefits coverage, which are often marketed as lower-cost, less comprehensive alternatives to ACA-compliant coverage. Because the bill targets a specific federal rule, its main legal effect would be on federal regulatory implementation and on the insurers, employers, and consumers affected by short-term coverage options.

Impact

If enacted, HB379 would override the 2024 federal rule governing short-term, limited-duration insurance and independent, noncoordinated excepted benefits coverage, removing the rule from legal effect. That would affect federal agencies' ability to enforce the new standards and could preserve or restore broader availability of short-term health insurance products and related coverage arrangements. The bill would primarily affect insurers, plan sponsors, employers, and consumers who use or offer these plans, especially in markets where such coverage is used as a lower-premium alternative to comprehensive health insurance.

Sentiment

The bill's framing and sponsorship suggest generally supportive sentiment among its backers toward expanding consumer choice and limiting federal regulation of short-term health coverage. The title "Healthcare Freedom and Choice Act" reflects a deregulatory, market-oriented approach. No committee transcript or vote record is available here, so there is no recorded opposition or floor debate in the provided materials, but the bill's subject matter indicates it is likely to be viewed favorably by supporters of less restrictive insurance options and skeptically by those who favor stronger consumer protections and ACA-aligned coverage standards.

Contention

The main point of contention is likely to be whether short-term, limited-duration insurance should be treated as a flexible, affordable option or as a product that can leave consumers with inadequate coverage. Supporters, including the bill's sponsors, appear to favor preserving access and choice by blocking the 2024 federal rule. Opponents would likely argue that the rule is needed to prevent misleading marketing, limit gaps in coverage, and protect consumers from plans that do not provide comprehensive benefits. Because no hearing transcript or vote history is provided, these positions are inferred from the bill's subject and title rather than from recorded debate.